MPN Congress 2022
Advertisement
Phase III VERIFY Trial of Rusfertide Enrolling Patients with Polycythemia Vera
Leah SherwoodMyeloproliferative Neoplasms | May 30, 2023
VERIFY, a phase III trial of the hepcidin mimetic rusfertide (PTG-300), is now enrolling patients with PV.
Read More
Single-Gene Analysis Deciphers Protein Role in Regulation of ECM Genes in MPNs
Leah SherwoodMyeloproliferative Neoplasms | December 27, 2022
IFN alpha-2 influences the regulation of several ECM genes involved in tissue remodeling.
Read More
Advertisement
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    Editorial Board

    About Us

    Terms of Use

    Advertising

    Privacy Policy

    Editorial Policy

    Our Network

    MashupMD

    GU Oncology Now

    Cancer Nursing Today

    Urban Health Today

    DocWire News

    Connect

    eNewsletters

    Calendar of Events

    Contact Us

    Contribute

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |